CJC-1295 with DAC – Long-Acting GHRH Analogue
CJC-1295 with DAC (Drug Affinity Complex) is a modified GHRH (growth hormone–releasing hormone) analogue engineered for extended half-life and sustained GH pulsatility in research models. The DAC modification allows the peptide to bind to serum albumin, significantly prolonging activity compared to Mod-GRF 1-29.
Aventris supplies high-purity, COA-verified CJC-1295 with DAC for controlled research applications.
Key Features
-
≥ 98–99% purity (HPLC verified)
-
DAC modification for extended half-life
-
Strong stability profile in vivo and in vitro models (research context)
-
Batch-specific COA + QR validation
-
Suited for GH axis, endocrine, metabolic, and recovery studies
Research Background
CJC-1295 with DAC is widely studied for:
-
GH/IGF-1 signalling pathways
-
Protein synthesis models
-
Metabolic regulation
-
Pituitary/hypothalamic mechanisms
-
Long-acting peptide pharmacokinetics
Specifications
| Parameter | Details |
|---|---|
| Name | CJC-1295 with DAC |
| Also Known As | DAC-CJC-1295 |
| Sequence | Modified GRF (1-29) with lysine-linker DAC attachment |
| CAS Number | 863288-34-0 |
| Molecular Weight | ~ 3367.9 g/mol (+ DAC complex) |
| Form | Lyophilised peptide |
| Purity | ≥ 98–99% |
| Appearance | White/Off-white powder |
| Solubility | Water / bacteriostatic water |
| Storage | −20°C long term |
| Research Use Only | Not for human or veterinary use |
Batch Verification
Each vial includes a unique QR code linking to its Aventris verification page.
Example URL:https://aventrislabs.com/verify/cjc-dac-01-2025/
What’s Included
-
1 × CJC-1295 with DAC (5mg)
-
QR-encoded batch authentication
-
COA link (digital)
